Neomycine-OVA

Neomycin-OVA is a conjugate of Neomycin and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

12352100

Biochemical Assay Reagents

Others

Inflammation/Immunology

[Neomycin-OVA]

[1]Liu Y, et al. Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. J Vet Pharmacol Ther. 2021 Sep;44 (5) :850-853.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-NP0249/

Biochemical Assay Reagents

No Development Reported